Deciphering the Transcription Factor Landscape in Prostate Cancer Progression: A Novel Approach to Understand NE Transdifferentiation

  • 0Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver, V5Z 1M9, Canada.

Summary

This summary is machine-generated.

This study identifies key transcription factors (TFs) driving prostate cancer (PCa) progression and neuroendocrine PCa (NEPC) development. Understanding these TF profiles offers new avenues for treating advanced, treatment-resistant prostate cancer.

Area Of Science

  • Oncology
  • Molecular Biology
  • Genetics

Background

  • Prostate cancer (PCa) is a major cause of male cancer mortality.
  • Treatment-induced neuroendocrine prostate cancer (NEPC) is an aggressive, ARPI-resistant subtype.
  • The role of transcription factors (TFs) in PCa progression and NEPC transdifferentiation is not well understood.

Purpose Of The Study

  • To identify lineage-specific TF profiles in prostatic adenocarcinoma and NEPC.
  • To understand TF expression dynamics during PCa progression and NEPC transdifferentiation.
  • To provide a molecular basis for adenocarcinoma to NEPC progression.

Main Methods

  • Developed an internal Z score-based approach to identify TF profiles.
  • Utilized Gene Ontology to validate biological and functional roles of TFs.
  • Performed knockdown experiments and longitudinal studies on NE transdifferentiation.

Main Results

  • Identified distinct TF profiles for adenocarcinoma and NEPC, including 126 shared, 46 adenocarcinoma-specific, and 56 NEPC-specific TFs.
  • Validated TF profiles across multiple cohorts.
  • Demonstrated that lineage-TFs are crucial for maintaining lineage-specific cell proliferation.
  • Proposed a three-phases hypothesis for PCa progression mechanisms based on dynamic TF expression shifts.

Conclusions

  • The study presents a novel approach to decipher the TF landscape in PCa.
  • Identified key TFs involved in PCa progression and NEPC transdifferentiation.
  • Findings provide a molecular basis for adenocarcinoma to NEPC progression and suggest potential therapeutic targets.

Related Concept Videos

Forced Transdifferentiation 01:28

1.9K

Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...

Tumor Progression 02:07

6.2K

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Methods of Nuclear Reprogramming 01:24

1.8K

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...

Transcription Factors 02:16

75.5K

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...

Master Transcription Regulators 02:23

6.8K

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...

Transcription 01:10

146.2K

Overview
Transcription is the process of synthesizing RNA from a DNA sequence by RNA polymerase. It is the first step in producing a protein from a gene sequence. Additionally, many other proteins and regulatory sequences are involved in the proper synthesis of messenger RNA (mRNA). Regulation of transcription is responsible for the differentiation of all the different types of cells and often for the proper cellular response to environmental signals.
Transcription Can Produce Different Kinds...